• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation.

作者信息

Hoffmann Markus, Behrens Georg M N, Arora Prerna, Kempf Amy, Nehlmeier Inga, Cossmann Anne, Manthey Luis, Dopfer-Jablonka Alexandra, Pöhlmann Stefan

机构信息

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.

Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; German Centre for Infection Research, partner site Hannover-Braunschweig, Hannover, Germany; Centre for Individualized Infection Medicine, Hannover, Germany.

出版信息

Lancet Infect Dis. 2023 Jan;23(1):25-28. doi: 10.1016/S1473-3099(22)00792-7. Epub 2022 Dec 5.

DOI:10.1016/S1473-3099(22)00792-7
PMID:36480944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9721839/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c07/9721839/115987094a63/gr1a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c07/9721839/115987094a63/gr1a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c07/9721839/115987094a63/gr1a_lrg.jpg

相似文献

1
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation.混合免疫和二价加强疫苗接种对奥密克戎亚谱系中和作用的影响。
Lancet Infect Dis. 2023 Jan;23(1):25-28. doi: 10.1016/S1473-3099(22)00792-7. Epub 2022 Dec 5.
2
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.先前感染和未感染个体接种奥密克戎二价加强针后针对原始 SARS-CoV-2 和奥密克戎 BA.5 的中和抗体和 T 细胞应答。
J Med Virol. 2023 Aug;95(8):e28989. doi: 10.1002/jmv.28989.
3
Development of hybrid immunity during a period of high incidence of Omicron infections.奥密克戎感染高发期间的混合免疫发展。
Int J Epidemiol. 2023 Dec 25;52(6):1696-1707. doi: 10.1093/ije/dyad098.
4
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model.针对奥密克戎的单克隆抗体和二价奥密克戎疫苗候选物在动物模型中引起强烈的病毒中和作用。
Sci Rep. 2024 Jan 2;14(1):268. doi: 10.1038/s41598-023-50822-w.
5
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity.针对单独感染、单独接种疫苗和混合免疫儿童的奥密克戎 BA.5 中和抗体。
Int J Infect Dis. 2023 Sep;134:18-22. doi: 10.1016/j.ijid.2023.05.005. Epub 2023 May 18.
6
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study.奥密克戎变异株特异性血清印迹在 BA.1 或 BA.4/5 双价疫苗接种和既往 SARS-CoV-2 感染后的情况：一项队列研究。
Clin Infect Dis. 2023 Nov 30;77(11):1511-1520. doi: 10.1093/cid/ciad402.
7
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months.接种疫苗后 6 个月，由疫苗单独或 SARS-CoV-2 感染加疫苗（混合免疫）诱导的抗体对奥密克戎（B.1.1.529）变异株的中和效果不佳。
EBioMedicine. 2022 Apr;78:103938. doi: 10.1016/j.ebiom.2022.103938. Epub 2022 Mar 16.
8
Real-world evidence on the efficacy of bivalent booster doses of SARS-CoV-2 vaccine in respect of monovalent boosters or primary cycle of vaccination: a narrative review.关于二价加强针相对于单价加强针或初始疫苗接种周期在 SARS-CoV-2 疫苗功效方面的真实世界证据：叙述性综述。
Epidemiol Prev. 2023 Nov-Dec;47(6):331-343. doi: 10.19191/EP23.6.A626.081.
9
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study.二价 mRNA 疫苗加强针预防 COVID-19 重症结局的有效性：一项回顾性队列研究。
Lancet Infect Dis. 2023 Aug;23(8):914-921. doi: 10.1016/S1473-3099(23)00122-6. Epub 2023 Apr 14.
10
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.在加拿大安大略省长期护理和退休之家居民中接种二价 SARS-CoV-2 mRNA-1273.214 疫苗后的早期体液和细胞反应：一项观察性队列研究。
J Med Virol. 2023 Oct;95(10):e29170. doi: 10.1002/jmv.29170.

引用本文的文献

1
Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice.基于混合脂肽的黏膜疫苗在小鼠中引发长期骨髓记忆反应，该反应可能对多种冠状病毒具有交叉反应性。
Front Immunol. 2025 Jul 28;16:1619882. doi: 10.3389/fimmu.2025.1619882. eCollection 2025.
2
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种状况与医护人员流感样疾病风险及工作日损失的关联。
Commun Med (Lond). 2025 Aug 9;5(1):347. doi: 10.1038/s43856-025-01046-8.
3

本文引用的文献

1
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.来自mRNA二价加强针的针对BA.2.75.2、BQ.1.1和XBB的中和作用。
N Engl J Med. 2023 Jan 12;388(2):183-185. doi: 10.1056/NEJMc2214293. Epub 2022 Dec 21.
2
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.原始mRNA疫苗或BA.5二价加强针 对SARS-CoV-2奥密克戎BA.2.75.2、BQ.1.1和XBB.1的中和作用较低。
Nat Med. 2023 Feb;29(2):344-347. doi: 10.1038/s41591-022-02162-x. Epub 2022 Dec 6.
3
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.
Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates.
免疫接种的多样性对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体功能替代指标有强烈影响。
NPJ Vaccines. 2025 Jul 29;10(1):175. doi: 10.1038/s41541-025-01226-6.
4
Clinicopathological characteristics and diagnostic performance of metagenomic pathogen detection technology in mycobacterial infections among HIV patients.宏基因组病原体检测技术在HIV患者分枝杆菌感染中的临床病理特征及诊断效能
Front Cell Infect Microbiol. 2025 Apr 29;15:1584189. doi: 10.3389/fcimb.2025.1584189. eCollection 2025.
5
Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.使用针对奥密克戎的mRNA疫苗或既往的新冠病毒疫苗进行加强免疫可引发针对奥密克戎变异株的特异性免疫反应。
Acta Pharm Sin B. 2025 Feb;15(2):947-962. doi: 10.1016/j.apsb.2024.12.030. Epub 2024 Dec 30.
6
Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV.HIV感染者对SARS-CoV-2奥密克戎BA.4/5 mRNA加强针的长期免疫反应。
Commun Med (Lond). 2025 Mar 27;5(1):92. doi: 10.1038/s43856-025-00799-6.
7
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.接种疫苗后感染后的循环中和抗体与SARS-CoV-2变体复制
JCI Insight. 2025 Mar 10;10(5):e185953. doi: 10.1172/jci.insight.185953.
8
Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffold.使用定制的马蹄形支架进行表位聚焦疫苗免疫原设计。
J Nanobiotechnology. 2025 Feb 18;23(1):119. doi: 10.1186/s12951-025-03200-9.
9
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.基于混合脂肽的黏膜疫苗候选物可诱导交叉变异免疫并保护仓鼠免受SARS-CoV-2感染。
Immunohorizons. 2025 Jan 24;9(2). doi: 10.1093/immhor/vlae011.
10
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections.多次接种新冠疫苗以及反复感染奥密克戎非 JN.1 或 JN.1 毒株后的奥密克戎亚变体中和作用及抗原图谱分析
Sci Rep. 2025 Jan 9;15(1):1454. doi: 10.1038/s41598-024-84138-0.
二价 SARS-CoV-2 mRNA 疫苗提高中和广度并预防小鼠感染奥密克戎变异株 BA.5。
Nat Med. 2023 Jan;29(1):247-257. doi: 10.1038/s41591-022-02092-8. Epub 2022 Oct 20.
4
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.针对新冠病毒奥密克戎亚谱系的印记抗体反应。
Science. 2022 Nov 11;378(6620):619-627. doi: 10.1126/science.adc9127. Epub 2022 Oct 20.
5
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies.奥密克戎亚谱系BA.2.75.2对中和抗体表现出广泛逃逸。
Lancet Infect Dis. 2022 Nov;22(11):1538-1540. doi: 10.1016/S1473-3099(22)00663-6. Epub 2022 Oct 14.
6
Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5.新出现的奥密克戎亚变体BA.2.12.1、BA.4和BA.5的中和抗性增强
Lancet Infect Dis. 2022 Aug;22(8):1117-1118. doi: 10.1016/S1473-3099(22)00422-4. Epub 2022 Jun 28.
7
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.BA.2.12.1、BA.4 和 BA.5 逃避奥密克戎感染诱导的抗体。
Nature. 2022 Aug;608(7923):593-602. doi: 10.1038/s41586-022-04980-y. Epub 2022 Jun 17.
8
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎亚变体BA.1、BA.2和BA.3的类似中和逃逸情况。
Lancet Infect Dis. 2022 Jun;22(6):766-767. doi: 10.1016/S1473-3099(22)00224-9. Epub 2022 Apr 12.
9
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.使用假型和嵌合病毒来测量 SARS-CoV-2 中和抗体活性。
J Exp Med. 2020 Nov 2;217(11). doi: 10.1084/jem.20201181.